Neurology & Rare Disorders
Huntington’s Disease (HD)
Huntington’s Disease (HD) is a rare, inherited neurological disorder that progressively affects movement, cognition, and behavior. CenExel partners with sponsors to advance innovative therapies through expert clinical research, specialized patient recruitment, and compassionate care for individuals and families impacted by HD.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Advancing Huntington’s Disease Clinical Research
CenExel’s experienced neuroscience research teams support Huntington’s Disease clinical trials with specialized operational expertise, patient-centered care, and advanced site capabilities. Our investigators work closely with sponsors to accelerate innovative therapies from early-phase studies through late-stage clinical development.
Conditions Covered
Huntington’s Disease Conditions We Research
Our neurology research sites support a broad range of Huntington’s Disease-related symptoms and associated neurodegenerative conditions.
- Huntington’s Disease (HD)
- Early-Stage Huntington’s Disease
- Juvenile Huntington’s Disease
- Cognitive Impairment in HD
- Behavioral & Psychiatric Symptoms
- Movement Disorders
- Chorea Associated with HD
- Neurodegenerative Disorders
Our Approach
Why Sponsors Choose CenExel for Huntington’s Disease Research
CenExel provides scientific leadership, operational excellence, and experienced neurology research teams to support successful Huntington’s Disease clinical trials.
01
CNS Research Expertise
Our teams specialize in complex neurology and neurodegenerative clinical trials.
02
Biomarker & Imaging Support
Advanced imaging and biomarker capabilities help support data-driven clinical outcomes.
03
Patient-Centered Care
Dedicated coordinators and caregiver support improve patient engagement and retention.
04
Diverse Research Network
CenExel’s nationwide site network enables broader access to HD patient populations.
Phase Coverage
Supported Trial Phases
CenExel supports Huntington’s Disease research across early and late-stage clinical development programs.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our neurology research teams support first-in-human studies, proof-of-concept trials, biomarker validation, and large multicenter HD studies with operational precision and scientific expertise.
Huntington’s Disease Task Force
CenExel supports innovative clinical trials focused on Huntington’s Disease and related neurodegenerative disorders, helping sponsors accelerate treatment development through specialized CNS expertise and experienced research sites.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
